Current financial headlines

Sharemaestro Newsreel

Financial news from across the world, newest first. Choose a country or market group, open the source, or continue into the company data.

Showing
253–288
Headlines
2622
Sources here
17
Companies here
19
Current section United States Diagnostics & Research news

Chronological news

Earlier headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

DirectorsTalk Interviews Earnings Main company 🇺🇸 United States

RadNet, Inc. (RDNT) Investor Outlook: Capitalizing on a 23.99% Potential Upside in the Booming Diagnostics Sector

RadNet, Inc. (RDNT) is positioned as a significant player in the diagnostics sector with a market capitalization of $5.69 billion. Analysts project a 23.99% potential upside, driven by strong revenue growth (22.10%) and strategic investments in AI and DeepHealth OS. While the company shows …

RDNT main company
Sharemaestro market context Price above Trend Line 52 weeks +7.3% RDNT stored weekly price path from 15 Aug 2025 to 7 Aug 2026
MarketBeat Analyst action Main company 🇺🇸 United States

Waters Corporation (NYSE:WAT) Given Average Recommendation of "Moderate Buy" by Analysts

Waters Corporation (NYSE:WAT) has received a "Moderate Buy" consensus rating from twenty analysts, with an average 12-month price target of $418.10. The company recently surpassed quarterly earnings and revenue expectations, reporting $3.05 in adjusted EPS and $1.65 billion in revenue. Shares are currently trading …

WAT main company
Sharemaestro market context Trend signal active 52 weeks +39.6% WAT stored weekly price path from 15 Aug 2025 to 7 Aug 2026
Sahm Earnings Main company 🇺🇸 United States

Does OPKO Health’s Sharply Narrowed Q2 Loss Reset the Bull Case for OPKO Health (OPK)?

OPKO Health, Inc. (OPK) reported a significantly narrowed net loss of US$8.42 million in Q2 2026, alongside increased revenue of US$163.58 million, which could signal progress in cost control and operations management. While the company remains unprofitable, this positive development, combined with their 2026 …

OPK main company DGX mentioned LH mentioned
Sharemaestro market context Trend signal active 52 weeks +0.0% OPK stored weekly price path from 15 Aug 2025 to 7 Aug 2026
Simply Wall Street Earnings Main company 🇺🇸 United States

Personalis (PSNL) Reports Higher Sales And Wider Losses, Does The Stock Look Fully Valued?

Personalis (PSNL) recently reported Q2 2026 results with increased sales but wider losses, leading to a reassessment of its stock by investors. Despite strong recent share price performance, the stock is currently trading slightly above analyst targets, with a narrative fair value suggesting it …

PSNL main company
Sharemaestro market context Trend signal active 52 weeks +207.8% PSNL stored weekly price path from 15 Aug 2025 to 7 Aug 2026
The Motley Fool Earnings Main company 🇺🇸 United States

What Investors Should Know About a Mettler-Toledo Director's Two Transactions This Past Week

A director at Mettler-Toledo International Inc. (MTD), Thomas P. Salice, recently sold 417 shares of the company, valued at approximately $600,651. This transaction was an exercise-and-sell of options, not a change in his long-term investment strategy, as he maintained significant indirect holdings. Mettler-Toledo has …

MTD main company
Sharemaestro market context Price above Trend Line 52 weeks +8.9% · Next-week setup positive 56.2% MTD stored weekly price path from 15 Aug 2025 to 7 Aug 2026
The Motley Fool Earnings Main company 🇺🇸 United States

A Mettler-Toledo Director Sold $600,000 in Stock. Here's What Investors Should Know

A director at Mettler-Toledo International Inc., Thomas P. Salice, sold 415 shares of common stock worth approximately $600,000 after exercising stock options. This transaction, occurring on August 3, was a same-day exercise and sale, where options acquired at a strike price of $397.95 were …

MTD main company
Sharemaestro market context Price above Trend Line 52 weeks +8.9% · Next-week setup positive 56.2% MTD stored weekly price path from 15 Aug 2025 to 7 Aug 2026
The Globe and Mail Earnings Main company 🇺🇸 United States

Mettler-Toledo's CFO Cashed In Options After a Strong Quarter. Here's What to Know

Mettler-Toledo International's CFO, Shawn Vadala, sold 2,240 shares for approximately $3.2 million on August 3, 2026, by exercising stock options. This transaction followed a strong quarter for the company, which reported significant revenue growth and raised its full-year outlook. Despite the sale, Vadala retains …

MTD main company
Sharemaestro market context Price above Trend Line 52 weeks +8.9% · Next-week setup positive 56.2% MTD stored weekly price path from 15 Aug 2025 to 7 Aug 2026
finance.yahoo.com Market update Main company 🇺🇸 United States

RadNet Inc (RDNT) (Q2 2026) Earnings Call Highlights: Record Revenue and AI-Driven Growth ...

This article first appeared on GuruFocus. Total Company Revenue: $622.7 million, up 25% from $498.2 million in Q2 2025. Total Company Adjusted EBITDA: $99.7 million, up 22.7% from $81.2 million in Q2 2025. Advanced Imaging Procedural Volumes: Aggregate volumes increased 21.2%; same-center volumes increased …

RDNT main company
Sharemaestro market context Price above Trend Line 52 weeks +7.3% RDNT stored weekly price path from 15 Aug 2025 to 7 Aug 2026
Stock Titan Earnings Main company 🇺🇸 United States

TWST shareholder (NASDAQ: TWST) files to sell 113,318 common shares

Emily M. Leproust, a shareholder of Twist Bioscience Corp (NASDAQ: TWST), has filed a Form 144 notice indicating her intent to sell 113,318 shares of common stock through Fidelity Brokerage Services LLC. The aggregate market value of this proposed sale is $14,183,056.89, with the …

TWST main company
Sharemaestro market context Trend signal active 52 weeks +311.3% TWST stored weekly price path from 15 Aug 2025 to 7 Aug 2026
Bitget Market update Main company 🇺🇸 United States

Guardant Health grants 46,044 RSUs to 149 new employees under inducement plan

Guardant Health has granted 46,044 Restricted Stock Units (RSUs) to 149 new non-executive employees under its 2023 Employment Inducement Incentive Award Plan. The grants were made on August 3, 2026, and will vest in three equal annual installments, contingent on continued employment. This news …

GH main company
Sharemaestro market context Trend signal active 52 weeks +186.1% GH stored weekly price path from 15 Aug 2025 to 7 Aug 2026
Investing.com Earnings Main company 🇺🇸 United States

Earnings call transcript: Insight Molecular Diagnostics posts mixed Q2 2026 results

* Insight Molecular Diagnostics Inc. (IMDX [https://seekingalpha.com/symbol/IMDX]) is scheduled to announce Q2 earnings results on Monday, August 10th, after market close. * The consensus EPS estimate is -$0.25, [https://seekingalpha.com/symbol/IMDX/earnings/estimates] and the consensus revenue estimate is $0.44M * Over the last year, IMDX has beaten …

IMDX main company
Sharemaestro market context Price below Trend Line 52 weeks +101.3% · Next-week setup negative 43.4% IMDX stored weekly price path from 15 Aug 2025 to 7 Aug 2026
nasdaq.com Market update Main company 🇺🇸 United States

A Natera Co-Founder Sold Into Record Highs. Here's What Long-Term Investors Should Know

Key Points The co-founder sold 9,150 shares for a total transaction value of approximately $2.9 million, based on the weighted-average execution price. The disposition reduced the insider's total equity holdings by 3% across direct and indirect accounts. Post-transaction ownership includes roughly 236,000 shares held …

NTRA main company
Sharemaestro market context Trend signal active 52 weeks +97.6% · Next-week setup positive 58.3% NTRA stored weekly price path from 15 Aug 2025 to 7 Aug 2026
Investing.com Earnings Main company 🇺🇸 United States

Insight Molecular Diagnostics earnings beat, revenue fell short of estimates

Insight Molecular Diagnostics (NASDAQ: IMDX) reported second-quarter EPS of $-0.230, exceeding analyst estimates of $-0.240. However, the company's revenue of $240K fell short of the consensus estimate of $470.85K. Despite the revenue miss, the company's stock price has shown significant volatility, being down -25.700% …

IMDX main company
Sharemaestro market context Price below Trend Line 52 weeks +101.3% · Next-week setup negative 43.4% IMDX stored weekly price path from 15 Aug 2025 to 7 Aug 2026
MarketBeat Earnings Main company 🇺🇸 United States

Thermo Fisher Scientific (NYSE:TMO) CAO Joseph Holmes Sells 420 Shares

Thermo Fisher Scientific's Chief Accounting Officer, Joseph Holmes, sold 420 shares of company stock for a total of $245,620.20, reducing his direct ownership by 12.4%. Despite the insider sale, Thermo Fisher shares rose 0.8%, and the company exceeded analyst expectations for both quarterly EPS …

TMO main company
Sharemaestro market context Price above Trend Line 52 weeks +21.9% TMO stored weekly price path from 15 Aug 2025 to 7 Aug 2026
MarketBeat Earnings Main company 🇺🇸 United States

Victoria Creamer Sells 4,179 Shares of Charles River Laboratories International (NYSE:CRL) Stock

Victoria Creamer, EVP of Charles River Laboratories International (NYSE:CRL), sold 4,179 shares for over $1.08 million, reducing her holdings by 12.21%. Despite the insider sale, the company recently reported strong quarterly earnings, beating estimates with $3.02 EPS and $1 billion in revenue, and analysts …

CRL main company
Sharemaestro market context Trend signal active 52 weeks +70.7% CRL stored weekly price path from 15 Aug 2025 to 7 Aug 2026
MarketWatch Market update Main company 🇺🇸 United States

Revvity Inc. stock underperforms Monday when compared to competitors despite daily gains

Revvity Inc. (RVTY) stock rose by 1.19% on Monday, closing at $116.02, marking its second consecutive day of gains. Despite this individual gain, the stock underperformed compared to the broader market, as the S&P 500 Index (SPX) fell 0.06% and the Dow Jones Industrial …

RVTY main company
Sharemaestro market context Trend signal active 52 weeks +26.6% RVTY stored weekly price path from 15 Aug 2025 to 7 Aug 2026
Stock Titan Market update Main company 🇺🇸 United States

Guardant Health (GH) holder plans 63,605-share stock resale

A Guardant Health (GH) shareholder, Chris Freeman, plans to resell up to 63,605 common shares through Charles Schwab & Co., Inc. The aggregate market value of these shares is $10,786,111.00, and the sale is linked to a cashless employee stock option exercise on August …

GH main company
Sharemaestro market context Trend signal active 52 weeks +186.1% GH stored weekly price path from 15 Aug 2025 to 7 Aug 2026
MarketBeat Earnings Main company 🇺🇸 United States

Michael Gunnar Knell Sells 6,645 Shares of Charles River Laboratories International (NYSE:CRL) Stock

Michael Gunnar Knell, Chief Accounting Officer at Charles River Laboratories International (NYSE:CRL), recently sold 6,645 shares of the company's stock for approximately $1.73 million, reducing his stake by 35.92%. Despite this insider selling, the company reported strong quarterly earnings, beating analyst estimates, and has …

CRL main company
Sharemaestro market context Trend signal active 52 weeks +70.7% CRL stored weekly price path from 15 Aug 2025 to 7 Aug 2026
MarketWatch Market update Main company 🇺🇸 United States

Waters Corp. stock outperforms competitors on strong trading day

Shares of Waters Corp. (WAT) increased by 1.21% to $411.77 on Monday, despite an overall downturn in the stock market where the S&P 500 Index and Dow Jones Industrial Average both saw slight declines. This marked the second consecutive day of gains for Waters …

WAT main company
Sharemaestro market context Trend signal active 52 weeks +39.6% WAT stored weekly price path from 15 Aug 2025 to 7 Aug 2026
MarketWatch Market update Main company 🇺🇸 United States

IDEXX Laboratories Inc. stock outperforms competitors on strong trading day

IDEXX Laboratories Inc. (IDXX) saw its stock rally by 1.55% to $595.76 on Monday, performing strongly despite an overall poor trading session for the broader market. The S&P 500 Index and Dow Jones Industrial Average both experienced declines. IDEXX Laboratories Inc. is currently trading …

IDXX main company
Sharemaestro market context Price below Trend Line 52 weeks -9.9% IDXX stored weekly price path from 15 Aug 2025 to 7 Aug 2026
KING5.com Earnings Main company 🇺🇸 United States

Insight Molecular Diagnostics: Q2 Earnings Snapshot

The provided content is not an article but rather a privacy notice or a placeholder. It does not contain any information about Insight Molecular Diagnostics or its Q2 earnings. Therefore, no meaningful summary can be generated.

DGX main company IMDX main company
Sharemaestro market context Trend signal active 52 weeks +34.3% · Next-week setup positive 57.4% DGX stored weekly price path from 15 Aug 2025 to 7 Aug 2026
BioSpace Earnings Main company 🇺🇸 United States

CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - August 7, 2026

CareDx, Inc. announced inducement grants of restricted stock units (RSUs) to 35 new employees as a material incentive for their employment. A total of 97,090 shares of common stock were awarded, with most RSUs vesting over four years and one employee's RSUs vesting 100% …

CDNA main company
Sharemaestro market context Trend signal active 52 weeks +294.3% CDNA stored weekly price path from 15 Aug 2025 to 7 Aug 2026
Stock Titan Earnings Main company 🇺🇸 United States

Charles River (CRL) finance chief sells 6,645 shares after exercising 2,345 options

Michael Gunnar Knell, SVP of Finance and Chief Accounting Officer at Charles River Laboratories International, Inc. (CRL), reported exercising 2,345 stock options and selling 6,645 shares of common stock on August 6, 2026. The options were exercised at strike prices between $179.66 and $208.44, …

CRL main company
Sharemaestro market context Trend signal active 52 weeks +70.7% CRL stored weekly price path from 15 Aug 2025 to 7 Aug 2026
MarketBeat Earnings Main company 🇺🇸 United States

Thermo Fisher Scientific Inc. $TMO Shares Sold by Franklin Street Advisors Inc. NC

Franklin Street Advisors Inc. NC reduced its stake in Thermo Fisher Scientific (NYSE:TMO) by 10.4% in the second quarter, selling 9,688 shares but still owning 83,653 shares valued at $41.9 million. Thermo Fisher Scientific reported strong quarterly earnings of $6.03 per share and $11.99 …

TMO main company
Sharemaestro market context Price above Trend Line 52 weeks +21.9% TMO stored weekly price path from 15 Aug 2025 to 7 Aug 2026
Stock Titan Market update Main company 🇺🇸 United States

James Foster (CRL) files Form 144 for 28,733-share option sale

James Foster, an insider at Charles River Laboratories International, Inc. (CRL), has filed a Form 144 indicating his plan to sell 28,733 shares of common stock. These shares will be acquired through the exercise of stock options for cash on August 10, 2026, with …

CRL main company
Sharemaestro market context Trend signal active 52 weeks +70.7% CRL stored weekly price path from 15 Aug 2025 to 7 Aug 2026
Stock Titan Market update Main company 🇺🇸 United States

Charles River (CRL) EVP Victoria Creamer exercises options and sells 4,179 shares

Victoria L. Creamer, EVP & Chief People Officer of Charles River Laboratories International, Inc. (CRL), exercised stock options for 4,179 shares at $179.66 per share and immediately sold them for $259.16 per share on August 6, 2026. This transaction resulted in approximately $332K pre-tax …

CRL main company
Sharemaestro market context Trend signal active 52 weeks +70.7% CRL stored weekly price path from 15 Aug 2025 to 7 Aug 2026
Simply Wall Street Capital return Provider-linked mention 🇺🇸 United States

Does JBT Marel’s (JBTM) Steady Guidance And Buybacks Reveal A New Capital Allocation Playbook?

JBT Marel Corporation reported stronger Q2 2026 results with higher sales and net income, reaffirming its full-year revenue guidance of US$3.99 billion to US$4.07 billion and GAAP diluted EPS of US$4.20 to US$4.70. The company also announced a US$26 million share buyback and a …

MTD mentioned
Sharemaestro market context Price above Trend Line 52 weeks +8.9% · Next-week setup positive 56.2% MTD stored weekly price path from 15 Aug 2025 to 7 Aug 2026
MarketWatch Earnings Main company 🇺🇸 United States

Danaher Corp. stock outperforms competitors on strong trading day

Danaher Corp. (DHR) shares rose 2.25% to $209.37 on a challenging trading day when the S&P 500 Index and Dow Jones Industrial Average both experienced declines. This marks the stock's fourth consecutive day of gains.

DHR main company
Sharemaestro market context Price above Trend Line 52 weeks -2.2% DHR stored weekly price path from 15 Aug 2025 to 7 Aug 2026
Investing.com Canada Market update Main company 🇺🇸 United States

Form 8K Insight Molecular Diagnostics Inc For: 10 August By Investing.com

This article announces the filing of a Form 8K by Insight Molecular Diagnostics Inc. on August 10. The filing is a standard regulatory announcement, and the article provides no further details beyond the company name and filing date. It appears to be a placeholder …

IMDX main company
Sharemaestro market context Price below Trend Line 52 weeks +101.3% · Next-week setup negative 43.4% IMDX stored weekly price path from 15 Aug 2025 to 7 Aug 2026
Stock Titan Earnings Main company 🇺🇸 United States

Insight Molecular Diagnostics (Nasdaq: IMDX) reports steep revenue drop but bolsters cash

Insight Molecular Diagnostics (IMDX) reported a steep revenue drop in Q2 2026, with net revenue down sharply to $239,000 from $518,000 in the prior year, and a net loss of $11.3 million. Despite the revenue decline and increased operating expenses, the company bolstered its …

IMDX main company
Sharemaestro market context Price below Trend Line 52 weeks +101.3% · Next-week setup negative 43.4% IMDX stored weekly price path from 15 Aug 2025 to 7 Aug 2026
Stock Titan Market update Main company 🇺🇸 United States

ADPT (ADPT) insider outlines Form 144 sale of 3,000 shares

A holder of Adaptive Biotechnologies Corp (ADPT) common stock has filed a Form 144, indicating an intention to sell 3,000 shares valued at $74,790.00 through Morgan Stanley Smith Barney. These shares are Restricted Stock Units acquired from the issuer on March 4, 2023. The …

ADPT main company
Sharemaestro market context Trend signal active 52 weeks +91.2% · Next-week setup positive 56.1% ADPT stored weekly price path from 15 Aug 2025 to 7 Aug 2026
The Manila Times Earnings Main company 🇺🇸 United States

IMDX Reports Second Quarter 2026 Results and Timely Progress on FDA Review of GraftAssureDx

Insight Molecular Diagnostics Inc. (IMDX) reported its Q2 2026 results and provided an update on the FDA review of its GraftAssureDx product. The company is progressing with the FDA, expecting marketing authorization soon, and highlighted favorable Medicare reimbursement policy changes. IMDX also shared clinical …

IMDX main company
Sharemaestro market context Price below Trend Line 52 weeks +101.3% · Next-week setup negative 43.4% IMDX stored weekly price path from 15 Aug 2025 to 7 Aug 2026
finance.yahoo.com Market update Main company 🇺🇸 United States

Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

PALO ALTO, Calif., August 10, 2026--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that on July 21, 2026, the Compensation Committee of Guardant's Board of Directors approved the granting of restricted stock units ("RSUs") representing 46,044 shares of its …

GH main company
Sharemaestro market context Trend signal active 52 weeks +186.1% GH stored weekly price path from 15 Aug 2025 to 7 Aug 2026
finance.yahoo.com Earnings Main company 🇺🇸 United States

QIAGEN Receives U.S. FDA Clearance for First QIAstat-Dx Bloodstream Infection Panel

QIAstat-Dx BCID GPF Plus AMR Panel detects 20 pathogen targets and 10 antimicrobial resistance markers from positive blood cultures in about one hour FDA clearance marks QIAGEN's entry into U.S. bloodstream infection testing and establishes the first member of a planned QIAstat-Dx BCID panel …

QGEN main company
Sharemaestro market context Price above Trend Line 52 weeks -14.7% QGEN stored weekly price path from 15 Aug 2025 to 7 Aug 2026
finance.yahoo.com Market update Provider-linked mention 🇺🇸 United States

Sector Update: Healthcare Stocks Gain Late Afternoon

Healthcare stocks were higher late Monday afternoon, with the NYSE Healthcare Index rising 1% and the State Street Health Care Select Sector SPDR ETF (XLV) adding 1.4%.The iShares Biotechnology ETF (IBB) climbed 1%.In corporate news, Eli Lilly (LLY) received UK authorization for Silver Upgrade …

TMO mentioned
Sharemaestro market context Price above Trend Line 52 weeks +21.9% TMO stored weekly price path from 15 Aug 2025 to 7 Aug 2026
GlobeNewswire Earnings Provider-linked mention 🇺🇸 United States

Alpha Tau Announces Second Quarter 2026 Financial Results and Provides Corporate Update

Alpha Tau Medical Ltd. reported its second-quarter 2026 financial results, highlighting significant clinical and corporate achievements. These include positive interim results from the REGAIN trial for recurrent glioblastoma, a strategic collaboration with Tolmar for prostate cancer, and the completion of patient enrollment for the …

LH mentioned
Sharemaestro market context Trend signal active 52 weeks +19.3% LH stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context